Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.
¡Compre este libro electrónico y obtenga 1 más GRATIS!
Formato EPUB ● Páginas 268 ● ISBN 9781315355900 ● Editor Kerry B. (Pfizer, Cambridge, Massachusetts, USA) Barker & Sr., Ralph B. (Boston University, Massachusetts, USA) D’Agostino ● Editorial CRC Press ● Publicado 2016 ● Descargable 3 veces ● Divisa EUR ● ID 5021283 ● Protección de copia Adobe DRM
Requiere lector de ebook con capacidad DRM